UX Agency Profile Arlington, Massachusetts Details Checked: 2026-11-05
GoInvo official logo

GoInvo.

Arlington, Massachusetts healthcare and clinical software design studio with documented cardiac monitoring and health IT case work. What does GoInvo do, what relevant work can you inspect, and what is not confirmed? Below is UXPicks’ shared agency profile combining confirmed headquarters, project-fit analysis, ownership caveats, and dated source links.

Brand Disambiguation & Collaborator Attribution Note: GoInvo’s Clutch profile had a limited review sample when checked on 2026-11-05, so UXPicks bases its candidate inclusion on GoInvo’s public healthcare and clinical portfolio (including the InfoBionic heart-monitoring case) rather than third-party rating scores.

Project Fit & Services (UXPicks Assessment)

Best suited for: Healthcare and clinical software.

Documented Service Areas

  • Healthcare & Clinical UX
  • Patient & Provider Software
  • Medical Data Visualization
  • Open-Source Health Design

Matching Project-Need Shortlists

Inclusion in a monthly shortlist does not place GoInvo onto every project-need page. Based on documented evidence, GoInvo is included in:

Monthly Edition Selections

This shared agency record is referenced by the following UXPicks monthly edition(s). Updating current agency facts here never rewrites historical edition selection reasons.

November 2026 Pick #8 · Unranked

November 2026: UX design agencies based in the United States

Month-specific selection reason: Healthcare and clinical software, including patient and provider product experiences.

Edition fact-checked: 2026-11-05 · View in November 2026 shortlist →
Evidence & Attribution Context: Case outcomes are attributed to GoInvo’s own account unless independently corroborated.

Cited Evidence & Verification Log (2 Sources)

UXPicks separates agency self-published claims, third-party client review profiles, and UXPicks editorial assessments. Inspect the primary sources below before contacting GoInvo.

# Evidence Type What This Source Supports Date Checked Source Link
#1 Agency-published case study Agency-published case about a mobile health design for real-time cardiac arrhythmia monitoring. 2026-11-05 Inspect source ↗
#2 Third-party profile (Clutch) Third-party profile and location information. 2026-11-05 Inspect source ↗

Frequently Asked Questions About GoInvo

Seven agency-specific questions answered from GoInvo’s cited sources checked on 2026-11-05.

What is GoInvo’s primary domain focus?

GoInvo is a specialist design studio focused on healthcare and clinical software, including patient-facing and clinician-facing digital products (checked November 5, 2026).

What documented project evidence supports GoInvo’s healthcare focus?

Among its public portfolio cases checked on November 5, 2026, GoInvo publishes an InfoBionic mobile health design case study covering real-time cardiac arrhythmia monitoring for clinicians and patients. Outcomes described in that case study are attributed to GoInvo’s published account.

Where is GoInvo located?

GoInvo is headquartered in Arlington, Massachusetts (greater Boston area), United States, as recorded on its Clutch profile and official site checked on November 5, 2026.

Why does UXPicks rely on GoInvo’s portfolio rather than third-party review volume?

GoInvo’s Clutch profile had a limited review sample when checked on November 5, 2026. UXPicks therefore bases GoInvo’s candidate selection on its specialized public healthcare portfolio rather than third-party rating scores.

Which project needs map to GoInvo on UXPicks?

GoInvo is mapped to Healthcare and Complex business software in the November 2026 candidate dataset.

Does UXPicks list pricing or team size for GoInvo?

No confirmed pricing or team-size figure is stored in the November 5, 2026 candidate record for GoInvo. Buyers should inquire directly at goinvo.com.

How is GoInvo featured in the November 2026 edition?

GoInvo is featured at display position 8 (unranked) in the November 2026 U.S. UX agency shortlist, checked on November 5, 2026.